Within a few years, autoantibodies targeting the nervous system resulted in a novel disease
classification. For several of them, which we termed 'established', direct pathogenicity has …

Autoantibodies produced by the patients' own immune systems in response to foreign
substances are emerging as an attractive biomarker for early detection of cancer. These …

Background Neurological immune-related adverse events (irAE-n) are severe and
potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical …

Cognitive dysfunction is a common feature of autoimmune encephalitis. Pathogenic
neuronal surface antibodies are thought to mediate distinct profiles of cognitive impairment …

Patients suffering from strokes are at increased risk of develo** post-stroke dementia.
Serum anti-NMDA receptor autoantibodies (NMDAR1-abs) have been associated with …

Background Cancer-related cognitive impairment is an important complication in cancer
patients, yet the underlying mechanisms remain unknown. Over the last decade, the field of …

Importance Paraneoplastic neurological syndromes are associated with neuronal
autoantibodies, and some of these autoantibodies are associated with neuropsychological …

The present knowledge on the (patho) physiological role of NMDAR1-AB is very limited and
still characterized by adamant rumors. Much more experimental work and more solid and …

Abstract Background Anti-NMDA-receptor GluN1 antibodies (NMDAR1-abs) are present in
an autoimmune encephalitis with severe neuropsychiatric symptoms. We aimed to estimate …

Serum neuronal autoantibodies, such as those to the NMDA receptor (NMDAR), are
detectable in a subgroup of patients with psychotic disorders. It is not known if they are …